Evidence map›Paper›PMID 34318364›Full record

Observational studyNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2021

Delirium in COVID-19 patients: a multicentric observational study in Italy.

Giovanni Martinotti, Laura Bonanni, Stefano Barlati, Andrea Miuli, Gianna Sepede, Davide Prestia, Alice Trabucco, Claudia Palumbo, Alessandra Massaro, Martina Olcese and 10 more

Open access · bronzeAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Corticosteroid Therapy in COVID-19 Associated With In-hospital Mortality in Geriatric Patients: A Propensity Matched Cohort Study.The journals of gerontology. Series A, Biological sciences and medical sciences · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 2 countries.

Giovanni MartinottiDepartment of Neuroscience, Imaging and Clinical Sciences, "G. D'Annunzio" University of Chieti, Chieti, Italy.
Laura BonanniDepartment of Neuroscience, Imaging and Clinical Sciences, "G. D'Annunzio" University of Chieti, Chieti, Italy.
Stefano BarlatiDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Andrea MiuliDepartment of Mental Health, ASL Lanciano-Vasto-Chieti, Viale Amendola 47, Chieti, Italy. andreamiuli@live.it.ORCID http://orcid.org/0000-0003-2431-0460
Gianna SepedeDepartment of Neuroscience, Imaging and Clinical Sciences, "G. D'Annunzio" University of Chieti, Chieti, Italy.
Davide PrestiaDepartment of Neuroscience, Ophthalmology, Genetics and Infant-Maternal Science, Section of Psychiatry, University of Genoa, Genoa, Italy.
Alice TrabuccoDepartment of Neuroscience, Ophthalmology, Genetics and Infant-Maternal Science, Section of Psychiatry, University of Genoa, Genoa, Italy.
Claudia PalumboDepartment of Psychiatry, Hospital Papa Giovanni XXIII, Bergamo, Italy.
Alessandra MassaroDepartment of Psychiatry, Hospital Papa Giovanni XXIII, Bergamo, Italy.
Martina OlcesePsychologist, Independent Researcher, Genoa, Italy.
Damiano D'ArdesDepartment of Medicine and Aging Sciences, University G. D'Annunzio of Chieti-Pescara, Chieti, Italy.
Francesco CipolloneDepartment of Medicine and Aging Sciences, University G. D'Annunzio of Chieti-Pescara, Chieti, Italy.
Mario AmoreDepartment of Neuroscience, Ophthalmology, Genetics and Infant-Maternal Science, Section of Psychiatry, University of Genoa, Genoa, Italy.
Emi BondiDepartment of Psychiatry, Hospital Papa Giovanni XXIII, Bergamo, Italy.
Mirella RussoDepartment of Neuroscience, Imaging and Clinical Sciences, "G. D'Annunzio" University of Chieti, Chieti, Italy.
Claudia CarrariniDepartment of Neuroscience, Imaging and Clinical Sciences, "G. D'Annunzio" University of Chieti, Chieti, Italy.
Marco OnofrjDepartment of Neuroscience, Imaging and Clinical Sciences, "G. D'Annunzio" University of Chieti, Chieti, Italy.
Stefano Luca SensiDepartment of Neuroscience, Imaging and Clinical Sciences, "G. D'Annunzio" University of Chieti, Chieti, Italy.
Antonio VitaDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Massimo di GiannantonioDepartment of Neuroscience, Imaging and Clinical Sciences, "G. D'Annunzio" University of Chieti, Chieti, Italy.
University of Chieti-Pescara · ITOspedale Papa Giovanni XXIII · ITUniversity of Genoa · ITUniversity of Brescia · ITUniversity of Hertfordshire · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAlthough recent data show that SARS-CoV-2 infection seems to affect the central nervous system (CNS), little is known about the neuropsychiatric effects resulting from this condition. In addition to the well-known neurotrophism of coronaviruses, recent evidence shows also that the "cytokine storm" induced by the infection is at the basis of the neuroinflammation of the CNS. Furthermore, prolonged hospitalization, polypharmacotherapy, and isolation could be at the basis of the onset of delirium in hospitalized COVID patients. This multicentric observational study explores the incidence of the onset of delirium in an Italian cohort of SARS-CoV-2 positive inpatients.

methodsData were collected in the COVIDhospitals of Brescia, Bergamo, Chieti, and Genova. Different socio-demographic, medical, neurological, and pharmacological parameters were collected. As a rapid screening for delirium, the 4AT scale was used. Eighty COVID-19 inpatients (mean age 74.7 ± 14.5 years) met the inclusion criteria (confirmed positivity to the SARS-CoV-2 virus; the presence of delirium and/or psychomotor agitation and/or new onset of other neuropsychiatric symptoms during hospitalization).

resultsThe majority of these patients (68.8%) had "hyperactive delirium" subtype. Polypharmacotherapy, current treatment with corticosteroids, and higher age were associated with delirium severity.

conclusionThese data provide an insight into the onset of delirium among COVID-19 patients underlining the need for monitoring, especially in elderly patients, the neuropsychiatric symptoms, and the therapy in order to have shorter hospitalization times and better outcomes.

Indexed as

COVID-19DeliriumAgedAged, 80 and overHospitalizationHumansItalyMiddle AgedSARS-CoV-2COVID-19DeliriumNeuroinflammationSARS-CoV-2 infection

Identifiers

PMID34318364
PMCPMC8316107
OpenAlexW3185390952

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.